Implant Sciences wins TSA’s explosive trace detection systems order

Implant Sciences has been awarded a contract by the US Transportation Security Administration (TSA) for the delivery of its explosives trace detection systems.

Under the $162m IDIQ contract, the company will deliver its QS-B220 desktop explosives trace detectors, which have been recently added to the TSA’s qualified products list (QPL) in the US for airport checkpoint passenger and baggage screening.

In addition, Implant Sciences will be responsible for delivering services for the new explosive trace detectors.

Implant Sciences CEO Glenn Bolduc said: "We are very pleased to receive an IDIQ of this magnitude from the TSA, just weeks after receiving approval for baggage and passenger screening.

"With this agreement, Implant Sciences becomes the first non-radioactive ETD manufacturer for passenger and baggage screening in airports."

Integrating a high-resolution colour touch-screen, the Quantum Sniffer QS-B220 desktop explosive and narcotics trace detector offers audio and visual alarm indications, including substance detection.

Further, the system uses non-radioactive Ion Mobility Spectrometry (IMS) analysis technology to rapidly detect and identify traces of a range of military, commercial, and homemade explosives, such as narcotic substances.

QS-B220’s radioactive material-free design, push-button maintenance and diagnostics, and a patented inCal internal automatic calibration system, further bolster the performance levels and convenience to desktop trace detection users with better accessibility.